BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30570164)

  • 1. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
    Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
    Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust beam orientation optimization for intensity-modulated proton therapy.
    Gu W; Neph R; Ruan D; Zou W; Dong L; Sheng K
    Med Phys; 2019 Aug; 46(8):3356-3370. PubMed ID: 31169917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
    Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
    Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
    Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
    Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.
    Liu W; Mohan R; Park P; Liu Z; Li H; Li X; Li Y; Wu R; Sahoo N; Dong L; Zhu XR; Grosshans DR
    Pract Radiat Oncol; 2014; 4(6):384-91. PubMed ID: 25407859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust mixed electron-photon radiation therapy optimization.
    Renaud MA; Serban M; Seuntjens J
    Med Phys; 2019 Mar; 46(3):1384-1396. PubMed ID: 30628079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel energy layer optimization framework for spot-scanning proton arc therapy.
    Gu W; Ruan D; Lyu Q; Zou W; Dong L; Sheng K
    Med Phys; 2020 Jun; 47(5):2072-2084. PubMed ID: 32040214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric impact of systematic spot position errors in spot scanning proton therapy of head and neck tumor.
    Yasui K; Omi Y; Shimomura A; Muramatsu R; Iwata H; Ogino H; Hayashi N
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust optimization of intensity modulated proton therapy.
    Liu W; Zhang X; Li Y; Mohan R
    Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
    Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
    Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
    Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
    Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
    An Y; Liang J; Schild SE; Bues M; Liu W
    Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fast robust optimizer for intensity modulated proton therapy using GPU.
    Xu Y; Chen J; Cao R; Liu H; Xu XG; Pei X
    J Appl Clin Med Phys; 2020 Mar; 21(3):123-133. PubMed ID: 32141699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
    Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
    Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
    Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
    Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Photon Intensity Modulated Radiation Therapy Robustness in Patients With Prostate Cancer as a Proposed Benchmark for Proton Therapy Robustness Evaluation.
    Maas JA; McDonald AM; Cardan RA; Snider JW; Fiveash JB; Kole AJ
    Pract Radiat Oncol; 2024; 14(1):e68-e74. PubMed ID: 37748679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.